Rvph investor notice: rosen, national trial lawyers, encourages reviva pharmaceuticals holdings, inc. investors to inquire about securities class action investigation - rvph

New york , may 10, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of reviva pharmaceuticals holdings, inc. (nasdaq: rvph) resulting from allegations that reviva pharmaceuticals may have issued materially misleading business information to the investing public. so what: if you purchased reviva pharmaceuticals securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
RVPH Ratings Summary
RVPH Quant Ranking